Trillium Therapeutics USA, LLC

MA · United States · Reporting entity ID 100001171894

Total reported 2019–2025

$9.71M

#497 of 2,960 reporting companies — 0% of all reported industry payments

$8K in general payments across 8 records, plus $9.70M in research funding across 1,095 records.

How it breaks down

General payments $7,951

Research funding $9,704,459

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.